Standout Papers
- Improved survival in multiple myeloma and the impact of novel therapies (2007)
- Review of 1027 Patients With Newly Diagnosed Multiple Myeloma (2003)
- Multiple Myeloma (2004)
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance (2002)
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients (2013)
- Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America (2007)
- Prevalence of Monoclonal Gammopathy of Undetermined Significance (2006)
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma (2008)
- Multiple myeloma (2017)
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study (2009)
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements (2012)
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial (2009)
- Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group (2005)
- Multiple myeloma (2008)
- Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis (2004)
- Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial (2016)
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma (2007)
- Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management (2020)
- Clonal competition with alternating dominance in multiple myeloma (2012)
- Multiple Myeloma: Diagnosis and Treatment (2016)
- Multiple myeloma: 2022 update on diagnosis, risk stratification, and management (2022)
- Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance (2018)
- Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management (2024)
Immediate Impact
8 by Nobel laureates 9 from Science/Nature 88 standout
Citing Papers
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
2024 Standout
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
2022 Standout
Works of S. Vincent Rajkumar being referenced
Multiple myeloma
2017 Standout
Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Vincent Rajkumar | 37605 | 32817 | 20954 | 885 | 52.1k | |
| Angela Dispenzieri | 24765 | 30738 | 15184 | 961 | 46.2k | |
| Morie A. Gertz | 20063 | 29428 | 13328 | 930 | 42.6k | |
| Paul G. Richardson | 31679 | 33345 | 22126 | 1.1k | 50.7k | |
| Bart Barlogie | 30064 | 24023 | 18006 | 696 | 41.6k | |
| Meletios Α. Dimopoulos | 23206 | 20698 | 22523 | 1.7k | 49.6k | |
| Shaji Kumar | 22717 | 22231 | 13685 | 1.0k | 33.9k | |
| Brian Druker | 29898 | 17055 | 10862 | 597 | 54.0k | |
| Philippe Moreau | 18794 | 17218 | 13840 | 989 | 31.1k | |
| Michael Andreeff | 15751 | 25506 | 13420 | 987 | 47.2k | |
| Nikhil C. Munshi | 21055 | 24747 | 16361 | 790 | 39.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...